HYFT
MindWalk Holdings Corp.
NASDAQ · Healthcare · Biotechnology · CA
$1.32
−0.75%Year over year
Reported trailing growth
- Revenue
- -15.9%
- EBITDA
- +54.1%
- EBIT
- -7.2%
- EPS
- +69.1%
- Free cash flow
- -79.2%
- Operating cash flow
- -95.2%
Forward estimates
Based on analyst estimates
- Revenue
- +2.6%
- EBITDA
- +25.2%
- EPS
- +21.7%
Three-year CAGR
- Revenue
- -9.5%
- EBITDA
- +54.5%
- EBIT
- -20.6%
- Net income
- +54.6%
- EPS
- +66.7%
- Free cash flow
- -75.7%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Apr 1, 2026